• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Voice Preservation

Making Our Voices Heard

Speech is a key part of a person’s identity. Voice matters to personal identity and expression, and connection with family and friends. The majority of people living with ALS/MND are eventually robbed of this fundamental part of their humanity.

This can be overcome using voice preservation technologies, but our research shows this is not equitably accessible. The Alliance seeks to provide universal access to technology to improve the quality of life of people living with ALS/MND. The ideal for every individual living with ALS/MND worldwide is to have the right to access voice preservation upon diagnosis.

The Voice Preservation Project

The Alliance, through a collaboration between Hospital Universitario Nacional de Colombia (HUN) and the Asociación Colombiana de ELA (ACELA), has launched a pilot project to deliver voice preservation technology to people living with ALS/MND in Colombia. This will serve as the basis on which future plans will be made on how best to scale to reach more people around the world.

If you would like to join us in expanding our reach to more people, please donate. We deeply appreciate your support.

Watch this video to find out more from the Alliance and its Information Technology Advisory Council (ITAC).

https://www.als-mnd.org/wp-content/uploads/2023/06/Voice-Preservation-ITAC-Intro.mp4

Watch this video to hear from Orlando Ruiz, founder of ACELA and a person living with ALS/MND, as he emphasizes the devastation of losing your voice. He goes on to explain the potential of voice banking technology to preserve dignity, autonomy and identity, and ensure no one loses their voice to ALS/MND.

 

Keep Up To Date

This project is in development and more details and information are coming soon! If you are interested in learning more, sign up to get periodic updates as the work progresses.

Subscribe

* indicates required
 
 

 

Disclaimer: Voice preservation is not designed, intended or made available for diagnosis, treatment or prevention of diseases or for use as a medical device. It is also not designed or intended to replace or be a substitute for professional medical advice, diagnosis, treatment or judgment.

Primary Sidebar

  • Daniel Hare, USA

    Daniel Hare, USA

  • Ada Garrido Benavidez, Mexico

    Ada Garrido Benavidez, Mexico

  • Bjarne Hytjanstorp, Norway

    Bjarne Hytjanstorp, Norway

  • Mikey Stone, ALS

    Mikey Stone, ALS

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Maurice LeClerc, Canada

    Maurice LeClerc, Canada

  • Steve Gallagher, Canada

    Steve Gallagher, Canada
    Picture1

  • Mary Thomas, Australia

    Mary Thomas, Australia

  • John Russo, USA

    John Russo, USA
    final3878

  • Jack Buzby, USA

    Jack Buzby, USA

  • Zabun Nassar, England

    Zabun Nassar, England

  • Susan Anderson, USA

    Susan Anderson, USA

  • Wendy Hendrickson, USA

    Wendy Hendrickson, USA

  • Fernando Ocampo Cardona, Colombia

    Fernando Ocampo Cardona, Colombia

  • Zelina Brito, Brazil

    Zelina Brito, Brazil

  • Soledad Rodriguez, Spain

    Soledad Rodriguez, Spain

  • Murat Morali, Turkey

    Murat Morali, Turkey

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Federica Mastrosimone, Italy

    Federica Mastrosimone, Italy

  • Hiroshi Matsuyama, Japan

    Hiroshi Matsuyama, Japan

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Feng Gin Sun, China

    Feng Gin Sun, China

  • Armando González Gómez, Colombia

    Armando González Gómez, Colombia

  • Inta Grubb, Australia

    Inta Grubb, Australia

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • JP

    JP

  • Eddy Lefrancois, Canada

    Eddy Lefrancois, Canada

  • João Marcos Andrietta, Brazil

    João Marcos Andrietta, Brazil

  • Osiel Mendoza, USA

    Osiel Mendoza, USA

  • Michael Lee, Australia

    Michael Lee, Australia

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Ali Var, Turkey

    Ali Var, Turkey

  • Yolanda Armendariz, Mexico

    Yolanda Armendariz, Mexico

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Teddy Hanono Annie, Mexico

    Teddy Hanono Annie, Mexico

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • Cassio Fernando da Silva, Brazil

    Cassio Fernando da Silva, Brazil

  • Art Eggert, USA

    Art Eggert, USA

  • Bob Simonds, USA

    Bob Simonds, USA

  • Maurice Leclerc, Canada

    Maurice Leclerc, Canada

  • David Watson, Scotland

    David Watson, Scotland

  • Sharon Corosanite, USA

    Sharon Corosanite, USA

  • Andrea Zicchieri, Italy

    Andrea Zicchieri, Italy
    AndreaZicchieri_conSLAncioItaly

  • Anna Barrow, UK

    Anna Barrow, UK

  • Chen Chun-Chin, Malaysia

    Chen Chun-Chin, Malaysia

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Juvenal Bayona Romero, Colombia

    Juvenal Bayona Romero, Colombia

  • Rolf Mauch, Switzerland

    Rolf Mauch, Switzerland

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login